Second, thus far, in cervical cancer the search for predictive biomarkers linked to the increased ability of cancer cells to protect their genome when challenged with chemotherapy or radiotherapy has been exclusively focused on nucleotide excision repair (NER) proteins, and in particular on the excision repair cross-complementation group1 (ERCC1) protein [9–13]. The gene discussed is ERCC1; the disease is cancer.